Stryker completes sale of U.S. spinal implants business
Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC.
'The sale of our spinal implants business enhances our strategic focus, positioning us to meet evolving customer needs and invest where we see the greatest opportunity for innovation and long-term growth,' said Kevin Lobo, Chair and CEO, Stryker. 'We remain committed to the spine space through our Interventional Spine, Neurotechnology and Enabling Technologies businesses, as well as our strategic partnership with VB Spine. We're grateful to our Spine team members for their contributions and confident they're well positioned for continued success.'
VB Spine will have exclusive access to Mako Spine and Copilot for use with its implants in spine procedures.
Certain international markets are expected to transfer to VB Spine at later dates, subject to the completion of all legal and regulatory requirements and required consultations with employees and/or employee representatives.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries: Kim Montagnino, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Tom's Guide
37 minutes ago
- Tom's Guide
OpenAI just signed a surprise deal with Google — here's why it matters
In a surprising twist in the AI arms race, OpenAI has signed a major deal with Google Cloud to access its infrastructure — even as ChatGPT competes directly with Google's own Gemini AI assistant. First reported exclusively by Reuters, the move signals a shift in strategy as OpenAI looks to scale its models faster and more reliably in the face of growing global demand. Since 2019, OpenAI has relied almost exclusively on Microsoft Azure as its cloud provider, thanks to Microsoft's multibillion-dollar investment and deep integration across tools like Copilot and Bing Chat. But that exclusivity appears to be softening. As reported by Reuters, OpenAI finalized a deal last month to begin tapping Google Cloud's powerful infrastructure, including its custom TPU chips. The reason is simple: capacity. As AI model training grows more resource-intensive, OpenAI is adopting a multi-cloud strategy to avoid overreliance on a single provider, and to keep pace with user demand. The deal with Google suggests OpenAI is seeking both scale and flexibility as it pushes into next-gen model development and possibly even its own chip design in the future. For Google, this is a huge credibility boost. OpenAI joins the ranks of high-profile clients like Anthropic and Apple who also rely on Google's data centers. It further positions Google Cloud as a serious contender in the battle for AI infrastructure dominance, thanks to its high-performance TPUs and deep engineering resources. Yes, OpenAI and Google are AI rivals, but in the cloud world, competition often takes a backseat to raw compute needs. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. 'This is less about rivalry and more about keeping hardware busy,' one source told Reuters. In short, cloud vendors will work with just about anyone if it keeps their data centers profitable. Going forward, this signals a turning point. OpenAI's deal with Google highlights a growing trend: cloud flexibility is now a competitive advantage. I think we can expect more AI companies to diversify their infrastructure, choosing performance and scalability over long-term exclusivity. In the AI era, even rivals need to share resources to survive.
Business Wire
2 hours ago
- Business Wire
ATKORE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Atkore Inc.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ('KSF'), announces that KSF has commenced an investigation into Atkore Inc. (NYSE: ATKR). In July 2024, the Company was named as a defendant in a number of civil antitrust lawsuits alleging that, from at least April 1, 2021, it and other U.S.-based PVC Pipe manufacturers conspired to artificially inflate the price of PVC Pipes through the exchange of competitively sensitive business information regarding PVC Pipe pricing and sales through an industry newsletter called Oil Price Information Service, LLC ('OPIS'), in violation of federal antitrust laws. Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information in violation of federal securities laws, which remains ongoing. KSF's investigation is focusing on whether Atkore's officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws. If you have information that would assist KSF in its investigation, or have been a long-term holder of Atkore shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn ( or visit to learn more. About Kahn Swick & Foti, LLC KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg. To learn more about KSF, you may visit
Business Wire
2 hours ago
- Business Wire
ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Elevation Oncology, Inc. (NasdaqCM: ELEV) to Concentra Biosciences, LLC. Under the terms of the proposed transaction, shareholders of Elevation will receive $0.36 in cash per share, plus one non-tradeable contingent value right representing the right to receive: (i) 100% of the closing net cash in excess of $26.4 million; and (ii) 80% of any net proceeds received within five years following closing from any disposition of EO-1022 that occurs within one year following closing. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. Please note that the transaction is structured as a tender offer, such that time may be of the essence. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit
